Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2010
Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776Julianne L Holleran, Robert A Parise, Archibong E Yellow-Duke, et al.The Journal of Pharmacology and Experimental Therapeutics|August 31, 2010
In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerizationDana M Clausen, Jianxia Guo, Robert A Parise, et al.Cancer Chemotherapy and Pharmacology|September 25, 2013
Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in miceRobert A Parise, Jan H Beumer, Dana M Clausen, et al.Current Reviews in Clinical and Experimental Pharmacology|August 12, 2020
Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in MiceJan H Beumer, Jianxia Guo, Evan C Ray, et al.Cancer Chemotherapy and Pharmacology|May 23, 2003
Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 ratsSteven M Musser, Merrill J Egorin, Eleanor G Zuhowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenograftsWilliam C Zamboni, Laura L Jung, Merrill J Egorin, et al.Anticancer Research|November 1, 2007
Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284)Jianxia Guo, Robert A Parise, Erin Joseph, et al.Journal of Pharmaceutical and Biomedical Analysis|December 16, 2017
Liquid chromatography-tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasmaSusan Christner, Jianxia Guo, Robert A Parise, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumorsJulie L Eiseman, Jianxia Guo, Ramesh K Ramanathan, et al.Cancer Chemotherapy and Pharmacology|October 26, 2016
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activationBrian F Kiesel, Robert A Parise, Jianxia Guo, et al.Pageof 7